Bioceres Crop Solutions Corp. Expected to Post FY2029 Earnings of $1.55 Per Share (NASDAQ:BIOX)

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Research analysts at Brookline Capital Management issued their FY2029 earnings per share estimates for Bioceres Crop Solutions in a research report issued on Tuesday, September 10th. Brookline Capital Management analyst K. Dolliver anticipates that the company will earn $1.55 per share for the year. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.30 per share.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its earnings results on Monday, September 9th. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.20 by ($0.23). The company had revenue of $124.30 million for the quarter, compared to analyst estimates of $126.75 million. Bioceres Crop Solutions had a return on equity of 0.28% and a net margin of 0.21%. During the same period in the previous year, the firm earned ($0.06) earnings per share.

Several other equities analysts have also commented on the stock. Oppenheimer dropped their price target on shares of Bioceres Crop Solutions from $17.00 to $16.00 and set an “outperform” rating on the stock in a research note on Wednesday. Lake Street Capital dropped their price objective on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday. Roth Capital raised Bioceres Crop Solutions to a “strong-buy” rating in a report on Tuesday, July 2nd. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a research report on Friday, July 19th. Finally, Roth Mkm reduced their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday. Four analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $13.63.

Bioceres Crop Solutions Trading Down 1.2 %

NASDAQ BIOX opened at $8.55 on Thursday. Bioceres Crop Solutions has a 52 week low of $8.16 and a 52 week high of $14.05. The firm has a 50 day moving average of $10.54 and a two-hundred day moving average of $11.47. The stock has a market capitalization of $536.91 million, a PE ratio of 855.00 and a beta of 0.49. The company has a quick ratio of 0.83, a current ratio of 1.22 and a debt-to-equity ratio of 0.29.

Hedge Funds Weigh In On Bioceres Crop Solutions

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Activest Wealth Management purchased a new position in Bioceres Crop Solutions during the 1st quarter worth $30,000. Cape Investment Advisory Inc. purchased a new position in shares of Bioceres Crop Solutions during the 4th quarter worth approximately $33,000. Oppenheimer & Co. Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at approximately $139,000. Lazard Asset Management LLC purchased a new stake in shares of Bioceres Crop Solutions in the first quarter valued at approximately $212,000. Finally, Ping Capital Management Inc. acquired a new position in Bioceres Crop Solutions during the second quarter worth $448,000. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.